home / stock / elym / elym news

ELYM News and Press, Eliem Therapeutics Inc From 06/27/22

Stock Information
Company Name: Eliem Therapeutics Inc
Stock Symbol: ELYM
Market: NASDAQ
Website: eliemtx.com
Menu
ELYM ELYM Quote ELYM Short ELYM News ELYM Articles ELYM Message Board
Get ELYM Alerts

News, Short Squeeze, Breakout and More Instantly...
ELYM - Eliem Therapeutics Announces Last Patient Completed Dosing in Phase 2a Study of ETX-810 in Patients with Lumbosacral Radicular Pain (LSRP)

Topline data from the Phase 2a clinical trial are expected in the third quarter of 2022 Virtual investor event to be held in July 2022 SEATTLE and CAMBRIDGE, United Kingdom, June 27, 2022 (GLOBE NEWSWIRE) -- Eliem Therapeutics, Inc., a clinical-stage biotechnology company ...
ELYM - FUV, ATNF and LOV among mid-day movers

Gainers: Tonix Pharmaceuticals Holding (TNXP) +60%. Helius Medical Technologies (HSDT) +40%. View (VIEW) +42%. Spark Networks (LOV) +32%. Regencell Bioscience Holdings (RGC) +21%. 180 Life Sciences (ATNF) +20%. Evelo Biosciences (EVLO) +17%. NeuroOne Medical Technologies Corporation (NMTC) +1...

ELYM - Elevation Oncology, Cue Biopharma top healthcare gainers, Verrica, PMV lead losers' pack

Gainers: Elevation Oncology (ELEV) +20%. Cue Biopharma (CUE) +14%. Evelo Biosciences (EVLO) +13%. GeoVax Labs (GOVX) +13%. Immix Biopharma (IMMX) +9%. Losers: Verrica Pharmaceuticals (VRCA) -58%. PMV Pharmaceuticals (PMVP) -10%. TransMedics (TMDX) ...

ELYM - Short Squeeze Stocks: VTNR, VERU and 3 Others Experts Think Are Ready to Pop

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Short squeeze stocks are trending as the market’s losses only widen Recession fears remain a growing concern amid global economic shortcomings Vertex Energy (NASDAQ: VTNR ) tops this week’s list as ...
ELYM - XERS, AGRX and LHDX among mid-day movers

Gainers: Data Storage Corporation (DTST) +40%. Indonesia Energy Corporation (INDO) +30%. Harpoon Therapeutics (HARP) +28%. Pulse Biosciences (PLSE) +24%. Praxis Precision Medicines (PRAX) +24%. Xeris Biopharma Holdings (XERS) +24%. Griffon Corporation (GFF) +22%. New Concept Energy (GBR) +20%...

ELYM - Harpoon Therapeutics, Grove top healthcare gainers; Chimerix, Eliem lead losers' pack

Gainers: Harpoon Therapeutics (HARP) +18%. Grove (GRVI) +11%. NanoViricides NNVC +11%. Travere Therapeutics TVTX +9%. Compass Therapeutics (CMPX) +4%. Losers: Chimerix CMRX -58%. Eliem Therapeutics ELYM -29%. Humacyte (HUMA) -20%. Va...

ELYM - Eliem Therapeutics GAAP EPS of -$0.50 beats by $0.06

Eliem Therapeutics press release (NASDAQ:ELYM): Q1 GAAP EPS of -$0.50 beats by $0.06. Cash, cash equivalents and short- and long-term marketable securities was $149.9 million as of March 31, 2022, as compared to $47.9 million as of March 31, 2021. Shares -2.27% PM. For further details see: ...
ELYM - Eliem Therapeutics Reports First Quarter Financial and Business Highlights

SEATTLE and CAMBRIDGE, United Kingdom, May 16, 2022 (GLOBE NEWSWIRE) -- Eliem Therapeutics, Inc. (Nasdaq: ELYM), a clinical-stage biotechnology company focused on developing novel therapies for neuronal excitability disorders to address unmet needs in chronic pain, psychiatry, epile...

ELYM - Nkarta, ERYTECH Pharma top healthcare gainers; Eliem, Clarus lead losers' pack

Gainers: Nkarta (NKTX) +84%. ERYTECH Pharma (ERYP) +54%. Sunshine Biopharma (SBFM) +25%. Rubius Therapeutics (RUBY) +17%. Quoin Pharmaceuticals (QNRX) +12%. Losers: Eliem Therapeutics (ELYM) -55%. Clarus Therapeutics Holdings (CRXT) -54%....

ELYM - Eliem stock tanks 54% as ETX-810 fails in diabetic pain study; delays enrollment in depression trial of ETX-155

Eliem Therapeutics (NASDAQ:ELYM) said a phase 2a trial of ETX-810 to treat diabetic peripheral neuropathic pain did not meet the goal of reducing pain intensity, and that the company has chosen to delay enrollment in studies of ETX-155 in depression. The company said ETX-810 is currently...
Previous 10 Next 10